D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
D. Boral Capital restated their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has a $46.00 price objective on the biotechnology company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $40.00 target price on […]
More Stories
Funko (NASDAQ:FNKO) Sets New 12-Month High – Here’s What Happened
Funko, Inc. (NASDAQ:FNKO – Get Free Report) shares hit a new 52-week high on Thursday . The stock traded as...
Deutsche Börse (OTCMKTS:DBOEY) Share Price Passes Below Fifty Day Moving Average – Here’s Why
Deutsche Börse AG (OTCMKTS:DBOEY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday...
Sprott Gold Miners ETF (NYSEARCA:SGDM) Stock Crosses Below 50 Day Moving Average – What’s Next?
Sprott Gold Miners ETF (NYSEARCA:SGDM – Get Free Report) passed below its 50 day moving average during trading on Tuesday...
Hudson’s Bay (OTCMKTS:HBAYF) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
Hudson’s Bay Co (OTCMKTS:HBAYF – Get Free Report) shares passed above its fifty day moving average during trading on Tuesday...
Boyd Group Income Fund (OTCMKTS:BFGIF) Shares Cross Below Fifty Day Moving Average – Here’s What Happened
Boyd Group Income Fund (OTCMKTS:BFGIF – Get Free Report)’s stock price crossed below its 50-day moving average during trading on...
Duckhorn Portfolio Completes Merger and Financial Arrangements
The Duckhorn Portfolio, Inc., a Delaware corporation, recently underwent a significant corporate event detailed in an 8-K filing with the...